The "Pharmaceutical Excipients Market by Products (Organic chemicals, Inorganic Chemicals), by Functionality (Fillers, Binders, Lubricants, Preservatives), by Route of Administration (Oral, Topical, Parenteral, Others)] - Global Forecast to 2019”analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=956

This report studies the global pharmaceutical excipients market, with forecast to 2019.

The pharmaceutical excipients market has witnessed a strong growth over the past few years. Investments by the pharmaceutical manufacturers on novel method of drug delivery have propelled the growth of this market. Further, rising focus on development of biologics and new excipients will also drive the excipients market during the forecast period. Recently, functional excipients have gained greater focus due to their applications in formulations employing newly developed active pharmaceutical ingredients. However, declining investments on R&D by excipients manufacturers, and stringent regulatory requirements curbing the number of the U.S. FDA approved manufacturing sites are factors that inhibit the growth of this market to a certain extent.

The global pharmaceutical excipients market is segmented by product, functionality, route of administration, and geography. It also discusses the key market drivers, restraints, opportunities, and challenges of this market and its sub-markets. While the market by products is segmented into organic and inorganic chemicals, the market by route of administration is sub-segmented into oral, topical, parenteral, and other excipients. The pharmaceutical excipients market was valued at $5,760.0 million in 2013 and is expected to grow at a healthy CAGR of 6.7% from 2014 to 2019.

North America is a major market for global pharmaceutical excipients which occupied a major share in this market, closely followed by Europe. Growth in investments on novel drug, and continuous efforts of pharmaceutical companies to offer superior-quality products are factors that have led to the large market shares of the North American and European pharmaceutical excipients markets.

The major players in the pharmaceutical excipients market are Ashland Inc. (U.S.), BASF SE (Garmany), The Dow Chemical Company (U.S.), Roquette (France), Colorcon, Inc. (U.S.), Avantor Performance Materials, Inc. (U.S.), FMC Corporation (U.S.), Evonik Industries (Germany), and Lubrizol Corporation (U.S.).

About MarketsandMarkets

MarketsandMarkets is the world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to a multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: [email protected]